Sumatriptan and Farxiga drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Farxiga (dapagliflozin). Common drug interactions include anal abscess among females and scrotal abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Farxiga. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Farxiga?

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 18,798 Farxiga users. Check the latest studies of Farxiga.



On Jul, 10, 2026

21 people who take Sumatriptan and Farxiga together, and have interactions are studied.

Sumatriptan and Farxiga drug interactions.

What are the common drug interactions of Sumatriptan and Farxiga, by gender? *:

female:

  1. Anal abscess
  2. Anxiety
  3. Genital abscess (build up of pus in genital)
  4. Necrosis (the death of body tissue)
  5. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  6. Perirectal abscess
  7. Tooth abscess (pus formation in tooth)
  8. Pain in extremity
  9. Asthma
  10. Blood pressure increased

male:

  1. Scrotal abscess (pus in scrotum)
  2. Cellulitis (infection under the skin)
  3. Arterial insufficiency (lack of enough blood flow through the arteries)
  4. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)
  5. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Myopia (difficult to see objects that are far away)
  8. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  9. Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
  10. Tremor (trembling or shaking movements in one or more parts of your body)

What are the common drug interactions of Sumatriptan and Farxiga, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cellulitis (infection under the skin)
  2. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  3. Scrotal abscess (pus in scrotum)
  4. Scrotal oedema (swelling of scrotum)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Testicular necrosis (damaged testes)
  7. Urinary tract infection
  8. Anal abscess
  9. Genital abscess (build up of pus in genital)

40-49:

  1. Anal abscess
  2. Anxiety
  3. Genital abscess (build up of pus in genital)
  4. Necrosis (the death of body tissue)
  5. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  6. Perirectal abscess
  7. Tooth abscess (pus formation in tooth)

50-59:

  1. Neuropathy peripheral (surface nerve damage)
  2. Peripheral swelling
  3. Retching (strong involuntary effort to vomit)
  4. Saliva altered (changes in saliva composition)
  5. Allergy to animal
  6. Asthma
  7. Bacterial infection
  8. Blood cholesterol increased
  9. Hypersensitivity
  10. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Pneumonia
  2. Chest pain
  3. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 5 people, 23.81%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 23.81%
  3. Weight Decreased: 3 people, 14.29%
  4. Type 2 Diabetes: 3 people, 14.29%
  5. Hypotension (abnormally low blood pressure): 3 people, 14.29%
  6. Immunodeficiency Common Variable: 2 people, 9.52%
  7. High Blood Pressure: 2 people, 9.52%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 9.52%
  9. Asthma: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Farxiga?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan and Farxiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Farxiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Farxiga and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and dapagliflozin (the active ingredients of Sumatriptan and Farxiga, respectively), and Sumatriptan and Farxiga (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: